Abstract
Large artery atherosclerosis (LAA) is a prevalent cause of acute ischemic stroke (AIS). Understanding the mechanisms linking atherosclerosis to stroke is essential for developing appropriate intervention strategies. Here, we found that the exosomal miRNA Novel-3 is selectively upregulated in the plasma of patients with LAA–AIS. Notably, Novel-3 was predominantly expressed in macrophage-derived foam cells, and its expression correlated with atherosclerotic plaque vulnerability in patients undergoing carotid endarterectomy. Exploring the function of Novel-3 in a mouse model of cerebral ischemia, we found that Novel-3 exacerbated ischemic injury and targeted microglia and macrophages expressing ionized calcium-binding adapter molecule 1 in peri-infarct regions. Mechanistically, Novel-3 increased ferroptosis and neuroinflammation by interacting with striatin (STRN) and downregulating the phosphoinositide 3-kinase–AKT–mechanistic target of rapamycin signaling pathway. Blocking Novel-3 activity or overexpressing STRN provided neuroprotection under ischemic conditions. Our findings suggest that exosomal Novel-3, which is primarily derived from macrophage-derived foam cells, targets microglia and macrophages in the brain to induce neuroinflammation and could serve as a potential therapeutic target for patients with stroke who have atherosclerosis.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
27,99 € / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
118,99 € per year
only 9,92 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout








Similar content being viewed by others
Data availability
High-throughput sequencing data have been deposited in the Genome Sequence Archive-Human database (HRA005998), the Gene Expression Omnibus database (GSE248793) and figshare (https://doi.org/10.6084/m9.figshare.26719024.v1)40. All data and methods supporting the findings of the study are available in the article and supplementary materials and are available from the corresponding authors upon reasonable request. Source data are provided with this paper.
References
Feigin, V. L. et al. World Stroke Organization (WSO): Global Stroke Fact Sheet 2022. Int. J. Stroke 17, 18–29 (2022).
Malhotra, K., Gornbein, J. & Saver, J. L. Ischemic strokes due to large-vessel occlusions contribute disproportionately to stroke-related dependence and death: a review. Front. Neurol. 8, 651 (2017).
Wang, Q. et al. A novel perspective on ischemic stroke: a review of exosome and noncoding RNA studies. Brain Sci. https://doi.org/10.3390/brainsci12081000 (2022).
Wang, C., Li, Z., Liu, Y. & Yuan, L. Exosomes in atherosclerosis: performers, bystanders, biomarkers, and therapeutic targets. Theranostics 11, 3996–4010 (2021).
Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654–659 (2007).
Kalani, M. Y. S. et al. Extracellular microRNAs in blood differentiate between ischaemic and haemorrhagic stroke subtypes. J. Extracell. Vesicles 9, 1713540 (2020).
De Smaele, E., Ferretti, E. & Gulino, A. MicroRNAs as biomarkers for CNS cancer and other disorders. Brain Res. 1338, 100–111 (2010).
Yang, K., Xiao, Q., Niu, M., Pan, X. & Zhu, X. Exosomes in atherosclerosis: convergence on macrophages. Int. J. Biol. Sci. 18, 3266–3281 (2022).
Colombo, M., Raposo, G. & Théry, C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu. Rev. Cell Dev. Biol. 30, 255–289 (2014).
Lovett, J. K., Gallagher, P. J., Hands, L. J., Walton, J. & Rothwell, P. M. Histological correlates of carotid plaque surface morphology on lumen contrast imaging. Circulation 110, 2190–2197 (2004).
Yi, J., Zhu, J., Wu, J., Thompson, C. B. & Jiang, X. Oncogenic activation of PI3K–AKT–mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis. Proc. Natl Acad. Sci. USA 117, 31189–31197 (2020).
Tanti, G. K., Pandey, P., Shreya, S. & Jain, B. P. Striatin family proteins: the neglected scaffolds. Biochim. Biophys. Acta Mol. Cell Res. 1870, 119430 (2023).
Zheng, S. et al. 17β-Estradiol upregulates striatin protein levels via Akt pathway in human umbilical vein endothelial cells. PLoS ONE 13, e0202500 (2018).
Li, S. et al. Identification of circular RNA hsa_circ_0001599 as a novel biomarker for large-artery atherosclerotic stroke. DNA Cell Biol. 40, 457–468 (2021).
Xiao, Q. et al. Comprehensive analysis of peripheral exosomal circRNAs in large artery atherosclerotic stroke. Front. Cell Dev. Biol. 9, 685741 (2021).
Xiao, Q. et al. Circulating exosomal circRNAs contribute to potential diagnostic value of large artery atherosclerotic stroke. Front. Immunol. 12, 830018 (2021).
Tang, Y. et al. Exosomal miR-27b-3p secreted by visceral adipocytes contributes to endothelial inflammation and atherogenesis. Cell Rep. 42, 111948 (2023).
Zhang, Z. G., Buller, B. & Chopp, M. Exosomes—beyond stem cells for restorative therapy in stroke and neurological injury. Nat. Rev. Neurol. 15, 193–203 (2019).
Tenchov, R. et al. Exosomes—nature’s lipid nanoparticles, a rising star in drug delivery and diagnostics. ACS Nano 16, 17802–17846 (2022).
Alim, I. et al. Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke. Cell 177, 1262–1279 (2019).
Jiao, L. et al. Iron metabolism mediates microglia susceptibility in ferroptosis. Front. Cell. Neurosci. 16, 995084 (2022).
Cui, Y. et al. ACSL4 exacerbates ischemic stroke by promoting ferroptosis-induced brain injury and neuroinflammation. Brain Behav. Immun. 93, 312–321 (2021).
Huang, Y. et al. UBIAD1 alleviates ferroptotic neuronal death by enhancing antioxidative capacity by cooperatively restoring impaired mitochondria and Golgi apparatus upon cerebral ischemic/reperfusion insult. Cell Biosci. 12, 42 (2022).
Ryan, S. K. et al. Microglia ferroptosis is regulated by SEC24B and contributes to neurodegeneration. Nat. Neurosci. 26, 12–26 (2023).
Kapralov, A. A. et al. Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death. Nat. Chem. Biol. 16, 278–290 (2020).
Absinta, M. et al. A lymphocyte–microglia–astrocyte axis in chronic active multiple sclerosis. Nature 597, 709–714 (2021).
Tang, D., Chen, X., Kang, R. & Kroemer, G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 31, 107–125 (2021).
Raz, L., Khan, M. M., Mahesh, V. B., Vadlamudi, R. K. & Brann, D. W. Rapid estrogen signaling in the brain. Neurosignals 16, 140–153 (2008).
Garza, A. E. et al. Critical role of striatin in blood pressure and vascular responses to dietary sodium intake. Hypertension 66, 674–680 (2015).
Garza, A. E. et al. Striatin heterozygous mice are more sensitive to aldosterone-induced injury. J. Endocrinol. 245, 439–450 (2020).
Chen, K., Xue, R., Geng, Y. & Zhang, S. Galangin inhibited ferroptosis through activation of the PI3K/AKT pathway in vitro and in vivo. FASEB J. 36, e22569 (2022).
Konoshenko, M. Y., Lekchnov, E. A., Vlassov, A. V. & Laktionov, P. P. Isolation of extracellular vesicles: general methodologies and latest trends. Biomed Res. Int. 2018, 8545347 (2018).
Meng, Y. et al. Direct isolation of small extracellular vesicles from human blood using viscoelastic microfluidics. Sci. Adv. 9, eadi5296 (2023).
Toledano, H., D’Alterio, C., Loza-Coll, M. & Jones, D. L. Dual fluorescence detection of protein and RNA in Drosophila tissues. Nat. Protoc. 7, 1808–1817 (2012).
Zhou, S. et al. Dandelion polysaccharides ameliorate high-fat-diet-induced atherosclerosis in mice through antioxidant and anti-inflammatory capabilities. Nutrients https://doi.org/10.3390/nu15194120 (2023).
Li, C.-Y. et al. Inhibition of mTOR pathway restrains astrocyte proliferation, migration and production of inflammatory mediators after oxygen–glucose deprivation and reoxygenation. Neurochem. Int. 83–84, 9–18 (2015).
Cheng, M. et al. Circulating myocardial microRNAs from infarcted hearts are carried in exosomes and mobilise bone marrow progenitor cells. Nat. Commun. 10, 959 (2019).
Zhang, Z. et al. The novel estrogenic receptor GPR30 alleviates ischemic injury by inhibiting TLR4-mediated microglial inflammation. J. Neuroinflammation 15, 206 (2018).
Jia, J. et al. CD11c+ microglia promote white matter repair after ischemic stroke. Cell Death Dis. 14, 156 (2023).
Dong, M. AS-exos exacerbates microglial ferroptosis-driven neuroinflammation. figshare https://doi.org/10.6084/m9.figshare.26719024.v1 (2024).
Acknowledgements
We thank Jiangsu Simcere Diagnostics for its technical support for the transcriptional analysis. We also thank S. Wang and R. Chen (Department of Neurosurgery, Tongji Hospital) for providing carotid endarterectomy samples. In addition, we are greatly indebted to all the patients who participated in the study, without whom this study would never have been accomplished. This study was funded by the Ministry of Science and Technology China Brain Initiative Grant (STI2030-Major Projects 2022ZD0204700 to W.W.), the National Natural Science Foundation of China (grants 82371404 to D.-S.T., 82271341 to C.Q. and 81873743 to D.-S.T.) and the Knowledge Innovation Program of Wuhan Shuguang Project (2022020801020454 to C.Q.).
Author information
Authors and Affiliations
Contributions
D.-S.T. is the lead contact for this article. D.-S.T., W.W., C.Q., M.-H.D., Y.T. and L.-Q.Z. conceptualized and designed the study. C.Q., M.-H.D., Y.T., Y.-H.C., L.-Q.Z., H.Z. and S.Y. analyzed the data. W.W., D.S.T., C.Q., M.H.D., L.Q.Z., L.Y.Z. and X.W.P. interpreted the data. D.S.T., C.Q., M.H.D. and L.F.Z. drafted the manuscript. W.W., D.-S.T., C.Q., M.-H.D., Y.T., Y.-H.C., L.-Q.Z., H.Z., S.Y., L.-Y.Z., X.-W.P. and L.-F.Z. made critical revisions to the manuscript. All authors were involved in the collection and critical review of data. All authors approved the final version of the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Aging thanks Marco Bacigaluppi, Lidia Garcia Bonilla and Zhaolong Zhang for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Additional data of small RNA sequencing.
Volcano plot and heatmap depicting differentially expressed plasma ex-miRNAs in LAA patients versus HD, SVO and CES, with Novel-3 highlighted.
Extended Data Fig. 2 Additional data of transcriptomic analysis of microglia both in vivo and in vitro.
a, Volcano plot depicting differentially expressed genes in microglia sorted from MCAO mice treated with Ctrl-exos or AS-exos. Dashed lines reveal fold change and significance thresholds. Up-regulated and down-regulated genes are shown in orange and blue, respectively. b,c, GSEA pathway analysis of differentially expressed genes, highlighting changes to ferroptosis-related, mitochondrion-related, and PI3K-AKT-mTOR pathways. The P value was estimated using an empirical phenotype-based permutation test. d, Heatmap of hierarchically differentially expressed genes in the pathways related to PI3K-AKT-mTOR signaling. e, Volcano plot depicting differentially expressed genes in HMC3 cells treated with LAA-exos or HD-exos. Dashed lines reveal fold change and significance thresholds. Up-regulated and down-regulated genes are shown in purple and blue, respectively. f,g, GSEA pathway analysis of differentially expressed genes, highlighting changes to mitochondrion-related, and PI3K-AKT-mTOR pathways. The P value was estimated using an empirical phenotype-based permutation test. h, Heatmap of hierarchically differentially expressed genes in the pathways related to inflammatory, ROS metabolic, and PI3K-AKT signaling.
Extended Data Fig. 3 Additional data of Novel-3-mediated ferroptosis and mitochondrial peroxidation of recipient microglia.
a, Representative images and quantitative analysis of intracellular Fe2+ levels (FerroOrange) (N = 6), mitochondrial superoxide (MitoSOX), and oxidized lipid (C11-BODIPY581/591). One-way ANOVA and Tukey’s multiple comparison tests. Data are shown as mean ± SD. b, Illustration of the experimental design of microglia sorting and quantitative analysis.
Extended Data Fig. 4 Coculture experiment of neurons and microglia.
a, Illustration of the in vitro experimental design of Coculture experiment of primary neurons and microglia. b, Representative images and quantitative analysis of MAP2+ neurons with proliferation marker (Ki67) (N = 6). Quantitative analysis of cell viability of MAP2+ neurons. One-way ANOVA and Tukey’s multiple comparison tests. Data are shown as mean ± SD.
Extended Data Fig. 5 Additional data of the in vivo treatment of AAV-Novel-3Sponge.
a, Representative immunostaining images and quantitative analysis showing that CreER protein were more distributed in the nucleus one week after tamoxifen injection than without tamoxifen (N = 6). The yellow arrows indicated cells without CreER protein distributed in the nucleus. The red arrows indicated cells with CreER protein distributed in the nucleus. Two-tailed unpaired t-test. Data are presented as mean ± SD. b, Representative images and quantitative analysis of STRN expression in Iba-1+ MM at 3days after MCAO treated with AAV-NC or AAV-Novel-3Sponge (N = 6). Two-tailed unpaired t-test. Data are presented as mean ± SD.
Extended Data Fig. 6 Novel-3 antagomiR showed neuroprotection against ischemic stroke.
a, Illustration of the in vivo experimental design injecting Novel-3 antagomir. b, Representative images and quantitative analysis of Cy3 labeled antagomiR-NC and antagomiR-Novel-3 colocalization with Iba1+ MM at 3 days after MCAO (N = 6). Two-tailed unpaired t-test. Data are shown as mean ± SD. c, Representative images of immunostaining showed Iba-1+ cells, 3D construction and sholl analysis in the peri-infarct areas of MCAO mice with daily administration of AS-exos and treatment of NC antagomiR or Novel-3 antagomiR (N = 6). Quantitative analysis of microglial density, and morphological changes including solidity, round, branch numbers and lengths, and end-point voxels. Two-tailed unpaired t-test. Data are shown as mean ± SD. d, Representative images and quantitative analysis of Iba-1+ microglia with lipid peroxidation marker (4-Hydroxynonenal, 4-HNE) and oxidized DNA marker (8-OHdG) at 3days after MCAO (N = 6). Two-tailed unpaired t-test. Data are shown as mean ± SD. e, Quantitative analysis of behavioral tests as measured by the mNSS, foot fault rate and rotarod test (N = 6). Two-tailed Mann-Whitney U tests and Two-way ANOVA tests for mNSS. Two-way ANOVA tests for foot fault rate and rotarod test. Data are presented as mean ± SD. f, Representative images and quantitative analysis of Nissl staining of MCAO mice with daily administration of AS-exos and treatment of NC antagomiR or Novel-3 antagomiR (N = 6). Black dashed lines indicate the border of infarct area. Dot plots indicated percentage of infarct area of individual mouse in each group. Two-tailed unpaired t-test. Data are presented as mean ± SD.
Extended Data Fig. 7 Additional data of attenuated Novel-3 induced microglial dysfunction and ischemic injury by overexpression of STRN.
a, RT-qPCR analysis and heatmap of genes in the pathways related to inflammatory responses, mitochondrial function, and ferroptosis. b, Representative images and quantitative analysis of intracellular Fe2+ levels (FerroOrange), and oxidized lipid (C11-BODIPY581/591) (N = 6). One-way ANOVA and Tukey’s multiple comparison tests. Data are shown as mean ± SD.
Extended Data Fig. 8 Graphic abstract.
Exosomal Novel-3, which originated predominantly from macrophage-derived foam cells, mainly targeted microglia to induce ferroptosis and neuroinflammation during ischemic stroke.
Supplementary information
Supplementary Tables
Supplementary Tables 1–13.
Source data
Source Data Figs. 1, 3, 5, 7 and 8
Unprocessed western blots and gels.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Qin, C., Dong, MH., Tang, Y. et al. The foam cell-derived exosomal miRNA Novel-3 drives neuroinflammation and ferroptosis during ischemic stroke. Nat Aging 4, 1845–1861 (2024). https://doi.org/10.1038/s43587-024-00727-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s43587-024-00727-8
This article is cited by
-
M2 microglia-derived small extracellular vesicles modulate NSC fate after ischemic stroke via miR-25-3p/miR-93-5p-TGFBR/PTEN/FOXO3 axis
Journal of Nanobiotechnology (2025)
-
Neuroferroptosis in health and diseases
Nature Reviews Neuroscience (2025)
-
Exploring the Nexus: How Ferroptosis, Microglia, and Neuroinflammation Converge in Ischemic Stroke Pathogenesis
Molecular Neurobiology (2025)